Literature DB >> 15508903

Utility of serodiagnostic tests for leprosy: a study in an endemic population in South India.

Sudhir Sinha1, S Kannan, B Nagaraju, U Sengupta, M D Gupte.   

Abstract

In order to evaluate the usefulness of natural disaccharide (PGL1) and 35 kDa antigens based serology in diagnosis of leprosy and in detecting high risk groups for leprosy, this study was conducted in an endemic population in South India. Out of 3346 cases and their households and neighbouring household contacts, serum samples from 2994 and 2875 individuals were screened for antibodies against PGL1 and 35kDa antigens respectively. While the overall positivity for contacts and leprosy cases was 3.3% for PGL1 antibody, the positivity for 35 kDa antibody was 6.3%. The positivity for contact population was 2.7% and 5.4% for PGL1 and 35 kDa antibodies, respectively. Lepromatous and borderline lepromatous patients showed positivity of 35.1% for PGL1 antibody and 45.7% for 35 kDa antibody. Follow-up of contacts showed that the majority (>90%) remained seronegative for both the antibodies and most of the new cases emerged from the seronegative group. The study clearly indicates that specific serological assays are not sensitive enough for application, both for diagnosis and for identifying any individual at risk for leprosy in the south Indian endemic population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15508903

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  5 in total

1.  Characterization of MicroRNA Expression Profiles and Identification of Potential Biomarkers in Leprosy.

Authors:  Karina T O S Jorge; Renan P Souza; Marieta T A Assis; Marcelo G Araújo; Massimo Locati; Amélia M R Jesus; Ida M F Dias Baptista; Cristiano X Lima; Antônio L Teixeira; Mauro M Teixeira; Frederico M Soriani
Journal:  J Clin Microbiol       Date:  2017-03-08       Impact factor: 5.948

2.  Rational design and evaluation of a multiepitope chimeric fusion protein with the potential for leprosy diagnosis.

Authors:  Malcolm S Duthie; Marah N Hay; Cecile Z Morales; Lauren Carter; Raodoh Mohamath; Lucia Ito; Luiza K M Oyafuso; Marli I P Manini; Marivic V Balagon; Esterlina V Tan; Paul R Saunderson; Steven G Reed; Darrick Carter
Journal:  Clin Vaccine Immunol       Date:  2009-12-16

3.  Evaluation of the social, clinical and laboratorial profile of patients diagnosed with leprosy in a reference center in São Paulo.

Authors:  Ana Carolina Souza Porto; Renata Borges Fortes Costa Figueira; Jaison Antônio Barreto; José Roberto Pereira Lauris
Journal:  An Bras Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.896

4.  IgM Anti PGL-1 Antibody Level in Patients with Leprosy: A Comparative Study between Ear Lobes Capillary and Median Cubital Vein Blood Samples.

Authors:  Khairina Nasution; Kristina Nadeak; Syahril Rahmat Lubis
Journal:  Open Access Maced J Med Sci       Date:  2018-08-16

Review 5.  Anti-PGL-1 Positivity as a Risk Marker for the Development of Leprosy among Contacts of Leprosy Cases: Systematic Review and Meta-analysis.

Authors:  Maria Lucia F Penna; Gerson O Penna; Paula C Iglesias; Sonia Natal; Laura C Rodrigues
Journal:  PLoS Negl Trop Dis       Date:  2016-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.